{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:50:44Z","timestamp":1791341444168,"version":"4.3.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jtho.2023.03.020","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T12:23:44Z","timestamp":1680092624000},"page":"1017-1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1148-551X","authenticated-orcid":false,"given":"Simon P.","family":"de Leeuw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda A.","family":"Pruis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barend J.","family":"Sikkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Mohseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. D. Marijn","family":"Veerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marthe S.","family":"Paats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne W.","family":"Dumoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert F.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemie M.W. J.","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron H.J.","family":"Mathijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth F.C.","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie C.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 7","key":"10.1016\/j.jtho.2023.03.020_bib1","doi-asserted-by":"crossref","first-page":"S1072","DOI":"10.1016\/j.annonc.2022.07.1266","article-title":"1142P The influence of food with different fat concentrations on alectinib exposure: a randomized cross-over pharmacokinetic trial","volume":"33","author":"Lanser","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2023.03.020_bib2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.annonc.2020.04.478","article-title":"Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study","volume":"31","author":"Mok","year":"2020","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.jtho.2023.03.020_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","article-title":"Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2023.03.020_bib4","doi-asserted-by":"crossref","first-page":"djv216","DOI":"10.1093\/jnci\/djv216","article-title":"The imperative for a new approach to toxicity analysis in oncology clinical trials","volume":"107","author":"Thanarajasingam","year":"2015","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.jtho.2023.03.020_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1704795","article-title":"Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer","volume":"377","author":"Peters","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2023.03.020_bib6","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jtho.2017.06.070","article-title":"Pooled systemic efficacy and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small cell lung cancer","volume":"12","author":"Yang","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.03.020_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S2213-2600(19)30053-0","article-title":"Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study","volume":"7","author":"Zhou","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtho.2023.03.020_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(17)30565-2","article-title":"Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial","volume":"390","author":"Hida","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2023.03.020_bib9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/annonc\/mdy121","article-title":"Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study","volume":"29","author":"Novello","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2023.03.020_bib10","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa2027187","article-title":"First-line lorlatinib or crizotinib in advanced ALK-positive lung cancer","volume":"383","author":"Shaw","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2023.03.020_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(17)30123-X","article-title":"First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study","volume":"389","author":"Soria","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2023.03.020_bib12","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1056\/NEJMoa1810171","article-title":"Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer","volume":"379","author":"Camidge","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2023.03.020_bib13","series-title":"Endotext [Internet]","article-title":"Drugs that affect body weight, body fat distribution, and metabolism","author":"Verhaegen","year":"2000"},{"issue":"suppl 1","key":"10.1016\/j.jtho.2023.03.020_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.orcp.2016.12.007","article-title":"Association between volume and glucose metabolism of abdominal adipose tissue in healthy population","volume":"11","author":"Kwon","year":"2017","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.jtho.2023.03.020_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/oby.22378","article-title":"Obesity as a disease: the Obesity Society 2018 position statement","volume":"27","author":"Jastreboff","year":"2019","journal-title":"Obesity"},{"key":"10.1016\/j.jtho.2023.03.020_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S1368980010001813","article-title":"The duration of obesity and the risk of type 2 diabetes","volume":"14","author":"Abdullah","year":"2011","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.jtho.2023.03.020_bib17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/ije\/dyr018","article-title":"The number of years lived with obesity and the risk of all-cause and cause-specific mortality","volume":"40","author":"Abdullah","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jtho.2023.03.020_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2337\/diacare.22.8.1266","article-title":"Weight change and\u00a0duration of overweight and obesity in the incidence of type 2 diabetes","volume":"22","author":"Wannamethee","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtho.2023.03.020_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jama.2013.7833","article-title":"Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age","volume":"310","author":"Reis","year":"2013","journal-title":"JAMA"},{"issue":"suppl 15","key":"10.1016\/j.jtho.2023.03.020_bib20","article-title":"ALINA: a phase III study of alectinib versus chemotherapy as adjuvant therapy in patients with stage IB\u2013IIIA anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC)","volume":"37","author":"Benjamin","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2023.03.020_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221103212","article-title":"Improving the tolerability of osimertinib by identifying its toxic limit","volume":"14","author":"Agema","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jtho.2023.03.020_bib22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2023.03.020_bib23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A\u00a0practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.jtho.2023.03.020_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaccao.2022.09.006","article-title":"Cardiac toxicity of alectinib in patients with ALK+ lung cancer","volume":"5","author":"Melinda","year":"2023","journal-title":"JACC Cardio Oncol"},{"key":"10.1016\/j.jtho.2023.03.020_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0148607115604149","article-title":"Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: a step-by-step guide for clinicians using National Institutes of Health ImageJ","volume":"40","author":"Gomez-Perez","year":"2016","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"10.1016\/j.jtho.2023.03.020_bib26","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jtho.2023.03.020_bib27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jss.2022.06.029","article-title":"Sarcobesity index predicts poor disease-specific survival after resection for colorectal cancer","volume":"279","author":"Conti","year":"2022","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jtho.2023.03.020_bib28","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.3390\/s22093357","article-title":"Concordance of computed tomography regional body composition analysis using a fully automated open-source neural network versus a reference semi-automated program with manual correction","volume":"22","author":"Gomez-Perez","year":"2022","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.jtho.2023.03.020_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jchromb.2019.03.011","article-title":"Quantification of afatinib, alectinib, crizotinib and osimertinib in human plasma by liquid chromatography\/triple-quadrupole mass spectrometry; focusing on the stability of osimertinib","volume":"1113","author":"Veerman","year":"2019","journal-title":"J\u00a0Chromatogr B"},{"key":"10.1016\/j.jtho.2023.03.020_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/obr.12836","article-title":"A\u00a0comprehensive diagnostic approach to detect underlying causes of obesity in adults","volume":"20","author":"van der Valk","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.jtho.2023.03.020_bib31","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A\u00a0critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jtho.2023.03.020_bib32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1073\/pnas.4.12.370","article-title":"A\u00a0biometric study of human basal metabolism","volume":"4","author":"Harris","year":"1918","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtho.2023.03.020_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diabet.2011.01.002","article-title":"How can we measure insulin sensitivity\/resistance?","volume":"37","author":"Antuna-Puente","year":"2011","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jtho.2023.03.020_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1472-6823-13-47","article-title":"Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study","volume":"13","author":"Gayoso-Diz","year":"2013","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jtho.2023.03.020_bib35","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jtho.2023.03.020_bib36","doi-asserted-by":"crossref","first-page":"448.e1","DOI":"10.1016\/j.jamda.2014.03.012","article-title":"New reference values for body composition by bioelectrical impedance analysis in the general population: results from the UK Biobank","volume":"15","author":"Franssen","year":"2014","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jtho.2023.03.020_bib37","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.ijo.0802037","article-title":"Fat-free mass index and fat mass index percentiles in Caucasians aged 18\u201398 y","volume":"26","author":"Schutz","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.jtho.2023.03.020_bib38","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/oby.21657","article-title":"Perceived weight discrimination and chronic biochemical stress: a population-based study using cortisol in scalp hair","volume":"24","author":"Jackson","year":"2016","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jtho.2023.03.020_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41380-018-0017-5","article-title":"Depression and obesity: evidence of shared biological mechanisms","volume":"24","author":"Milaneschi","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jtho.2023.03.020_bib40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000442721","article-title":"European guidelines for obesity management in adults","volume":"8","author":"Yumuk","year":"2015","journal-title":"Obes Facts"},{"key":"10.1016\/j.jtho.2023.03.020_bib41","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2023.03.020_bib42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bjh.12935","article-title":"Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies","volume":"166","author":"Teras","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtho.2023.03.020_bib43","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1200\/JCO.2004.07.121","article-title":"Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114","volume":"22","author":"Meyerhardt","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2023.03.020_bib44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/21681805.2013.803151","article-title":"Role of abdominal obesity for functional outcomes and complications in men treated with radical prostatectomy for prostate cancer: results of the Multicenter Italian Report on Radical Prostatectomy (MIRROR) study","volume":"48","author":"Gacci","year":"2014","journal-title":"Scand J Urol"},{"key":"10.1016\/j.jtho.2023.03.020_bib45","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2012.41.8574","article-title":"Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review","volume":"30","author":"Paskett","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2023.03.020_bib46","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/jnci\/djt223","article-title":"Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity","volume":"105","author":"Schmitz","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtho.2023.03.020_bib47","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2020.23130","article-title":"Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in the United States","volume":"324","author":"Sung","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jtho.2023.03.020_bib48","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/jnci\/djab053","article-title":"Body mass index and risk of second cancer among women with breast cancer","volume":"113","author":"Feigelson","year":"2021","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtho.2023.03.020_bib49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/met.2017.0166","article-title":"Untangling waist circumference and hip circumference from body mass index with a body shape index, hip index, and anthropometric risk indicator","volume":"16","author":"Krakauer","year":"2018","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jtho.2023.03.020_bib50","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.21.01626","article-title":"Targeted therapies for lung cancer patients with oncogenic driver molecular alterations","volume":"40","author":"Tan","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl 2","key":"10.1016\/j.jtho.2023.03.020_bib51","doi-asserted-by":"crossref","first-page":"S957","DOI":"10.1016\/j.dsx.2017.07.022","article-title":"Longitudinal changes in visceral and subcutaneous adipose tissue and metabolic syndrome: results from the Multicultural Community Health Assessment Trial (M-CHAT)","volume":"11","author":"Tu","year":"2017","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.jtho.2023.03.020_bib52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.nutres.2015.04.002","article-title":"Sarcopenic obesity is associated with lower indicators of psychological health and quality of life in Koreans","volume":"35","author":"Cho","year":"2015","journal-title":"Nutr Res"},{"key":"10.1016\/j.jtho.2023.03.020_bib53","article-title":"Effect of 12-month resistance training on changes in abdominal adipose tissue and metabolic variables in patients with prediabetes: a randomized controlled trial","volume":"2019","author":"Yan","year":"2019","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.jtho.2023.03.020_bib54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s13679-019-00335-3","article-title":"Metformin: mechanisms in human obesity and weight loss","volume":"8","author":"Yerevanian","year":"2019","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.jtho.2023.03.020_bib55","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4093\/dmj.2020.0258","article-title":"Comprehensive review of current and upcoming anti-obesity drugs","volume":"44","author":"Son","year":"2020","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jtho.2023.03.020_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182211861","article-title":"HealthyLIFE, a combined lifestyle intervention for overweight and obese adults: a descriptive case series study","volume":"18","author":"Philippens","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"suppl 7","key":"10.1016\/j.jtho.2023.03.020_bib57","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1038\/ijo.2008.247","article-title":"WHO recognition of the global obesity epidemic","volume":"32","author":"James","year":"2008","journal-title":"Int J Obes"},{"key":"10.1016\/j.jtho.2023.03.020_bib58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/cpt.1989","article-title":"Exposure-response analyses of anaplastic lymphoma kinase inhibitors crizotinib and alectinib in non-small cell lung cancer patients","volume":"109","author":"Groenland","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtho.2023.03.020_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.lungcan.2019.11.025","article-title":"Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer","volume":"139","author":"Nakagawa","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2023.03.020_bib60","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/cpt.2228","article-title":"Lorlatinib exposure-response analyses for safety and efficacy in a phase I\/II trial to support benefit-risk assessment in non-small cell lung cancer","volume":"110","author":"Chen","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtho.2023.03.020_bib61","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2018-0380","article-title":"Clinical management of adverse events associated with lorlatinib","volume":"24","author":"Bauer","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.jtho.2023.03.020_bib62","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cell.2020.04.034","article-title":"Identification of ALK in thinness","volume":"181","author":"Orthofer","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jtho.2023.03.020_bib63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.lungcan.2022.08.008","article-title":"Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: results of the ETOP ALERT-lung trial","volume":"172","author":"Felip","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2023.03.020_bib64","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.3390\/ijms21197108","article-title":"RET receptor tyrosine kinase: role in neurodegeneration, obesity, and cancer","volume":"21","author":"Mahato","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtho.2023.03.020_bib65","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2005653","article-title":"Efficacy of selpercatinib in RET fusion-positive non-small-cell lung cancer","volume":"383","author":"Drilon","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2023.03.020_bib66","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3390\/ijms19072043","article-title":"Role of mTOR in glucose and lipid metabolism","volume":"19","author":"Zhuo Mao","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtho.2023.03.020_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1136221","article-title":"Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)","volume":"13","author":"Meertens","year":"2023","journal-title":"Front Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086423002198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086423002198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T21:14:16Z","timestamp":1722546856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086423002198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1556086423002198"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2023.03.020","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2023.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}]}}